The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 2-(2-(3'-(Aminomethyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)acetate ID: ALA4473829
PubChem CID: 90480060
Max Phase: Preclinical
Molecular Formula: C23H22N2O3
Molecular Weight: 374.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Cc1ccccc1NC(=O)c1cccc(-c2cccc(CN)c2)c1
Standard InChI: InChI=1S/C23H22N2O3/c1-28-22(26)14-19-7-2-3-11-21(19)25-23(27)20-10-5-9-18(13-20)17-8-4-6-16(12-17)15-24/h2-13H,14-15,24H2,1H3,(H,25,27)
Standard InChI Key: NJQXPHXXASFTHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
28.1171 -2.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1132 -3.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8208 -3.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5288 -3.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5249 -2.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8168 -2.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8238 -4.8120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1149 -5.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1155 -6.0372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8242 -6.4459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5338 -6.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5298 -5.2170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4081 -6.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4086 -7.2635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2305 -2.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9403 -2.7607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2263 -1.5386 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6459 -2.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3539 -2.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0591 -2.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0553 -1.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3405 -1.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6383 -1.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3554 -3.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0638 -3.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0652 -4.8001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7708 -3.5731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4792 -3.9805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
9 13 1 0
13 14 1 0
5 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
19 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1630AlogP: 3.78#Rotatable Bonds: 6Polar Surface Area: 81.42Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.24CX LogP: 3.62CX LogD: 1.80Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.89
References 1. Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M.. (2019) Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway., 62 (9): [PMID:30995036 ] [10.1021/acs.jmedchem.9b00271 ]